Whole-Body Muscle Magnetic Resonance Imaging in Glycogen-Storage Disease Type III.


Journal

Muscle & nerve
ISSN: 1097-4598
Titre abrégé: Muscle Nerve
Pays: United States
ID NLM: 7803146

Informations de publication

Date de publication:
07 2019
Historique:
accepted: 09 04 2019
pubmed: 12 4 2019
medline: 28 10 2019
entrez: 12 4 2019
Statut: ppublish

Résumé

The main objective of this study was to describe muscle involvement on whole-body magnetic resonance imaging scans in adults at different stages of glycogen-storage disease type III (GSDIII). Fifteen patients, 16-59 years of age, were examined on a 3-T system. The examinations consisted of coronal and axial T1-weighted images or fat images with a Dixon technique, and were scored for 47 muscles using Mercuri's classification. Muscle changes consisted of internal bright signals of fatty replacement. Distribution across muscles showed predominant signal alteration in the lower limbs and postural muscles. This finding is consistent with the overall clinical presentation of GSDIII and the results of heatmap scores. Review of the MRI scans provided new information regarding recurrent muscle changes, particularly in the soleus, gastrocnemius medial head, and thoracic extensor muscles. Whole-body muscle imaging provides clinically relevant information regarding muscle involvement in GSDIII. A severity score may contribute to improved patient management. Muscle Nerve, 2019.

Identifiants

pubmed: 30972778
doi: 10.1002/mus.26483
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

72-79

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

David Tobaly (D)

APHP, Service de Radiologie GHU PIFO pôle neuro-locomoteur, Hôpital Raymond Poincaré, Garches, France.

Pascal Laforêt (P)

AP-HP, Service de Neurologie, Hôpital Raymond-Poincaré, Garches, France.
Centre de référence des maladies neuromusculaires Nord/Est/Ile de France, France.

Ariane Perry (A)

Université Paris-Diderot-Sorbonne Paris Cité, UMR 1149, Paris, France.

Dalila Habes (D)

AP-HP, Service de pédiatrie, Hôpital Bicêtre, Kremlin-Bicêtre, France.

Philippe Labrune (P)

APHP, Hôpital Antoine Béclère, Centre de Référence Maladies Héréditaires du Métabolisme Hépatique, Hôpitaux Universitaires Paris Sud, Clamart, France.

Valerie Decostre (V)

AIM-Institute of Myology, Paris, France.

Marion Masingue (M)

Centre de référence des maladies neuromusculaires Nord/Est/Ile de France, Hôpital Pitié-Salpêtrière, APHP, Paris, France.

Francois Petit (F)

APHP, Laboratoire de Génétique Moléculaire, Hôpitaux Universitaires Paris-Sud, Hôpital Antoine Béclère, Clamart, France.

Andrea Barp (A)

Department of Neurosciences, University of Padova, Padova, Italy.

Luca Bello (L)

Department of Neurosciences, University of Padova, Padova, Italy.

Pierre Carlier (P)

AIM & CEA NMR Laboratory, Institute of Myology, Pitié-Salpêtrière University Hospital, Paris, France.

Robert-Yves Carlier (RY)

APHP, Service de Radiologie GHU PIFO pôle neuro-locomoteur, Hôpital Raymond Poincaré, Garches, France.
Centre de référence des maladies neuromusculaires Nord/Est/Ile de France, France.
UMR 1179, Université Versailles Saint Quentin en Yvelines, Paris Saclay, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH